Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 19.90
-0.40 (-1.97%)
At close: Aug 3, 2026
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 891.33 million as of August 4, 2026. Its market cap has decreased by -17.28% in one year.
Market Cap
891.33M
Enterprise Value
885.50M
Revenue
449.47M
Ranking
n/a
PE Ratio
11.96
Stock Price
19.90
ChartMarket Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 891.33M, an increase of 176.52%. That is a compound annual growth rate of 9.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 891.33M | -3.37% |
| Dec 30, 2025 | 922.37M | -12.24% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.13B |
| Thor Medical ASA | 2.08B |
| Circio Holding ASA | 1.95B |
| Nordhealth AS | 1.89B |
| Nykode Therapeutics AS | 1.10B |
| ArcticZymes Technologies ASA | 1.00B |
| INIFY Laboratories AB | 859.80M |
| Omda AS | 773.14M |